PRF1 and cancer: CYT quantified the cytolytic activity of the local immune infiltrate based on transcript levels of two key cytolytic effectors, granzyme A (GZMA) and perforin (PRF1), which represented the process of killing cancer cells that tumor immunotherapy strategies aim to boost [57].